Stellate Ganglion Block in the Treatment of Long COVID: A Systematic Review
Current Pain and Headache Reports · 2026-12 · 30 (1)
DOI: 10.1007/s11916-026-01477-5 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Current Pain and Headache Reports, online erschienen am 13.04.2026. Verfasst von Sudeep Peddireddy und 4 weiteren Autor:innen. Beteiligte Einrichtung: Temple University, 3401 N. Broad St, Philadelphia, PA, 19140, USA. Sudeeprpeddireddy@gmail.com. Hauptthemen laut MEDLINE: Autonomic Nerve Block, Post-Acute COVID-19 Syndrome, Stellate Ganglion. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objectives
This review evaluates stellate ganglion block as a treatment for long COVID, seeking to evaluate the treatment’s efficacy by various symptoms and the limitations of the current literature. Study Design Systematic Review.
Setting
Ambulatory or Outpatient Setting. Methods, Subjects A systematic review of the current literature regarding use of stellate ganglion block in patients with long COVID was conducted. 2 databases were searched on August 28th, 2025. Search terms were “long COVID” and “stellate ganglion block”, yielding 45 results. Studies examining patient outcomes after stellate ganglion block were included. Case reports, case series, basic science studies and previous reviews were excluded. Seven studies met inclusion criteria.
Results
Patients received a single stellate ganglion block in some studies and multiple stellate ganglion blocks in others. All studies reported symptomatic improvement without control groups. Response rates ranged from 55.8% to 100%. The most robust improvements (> 80% patients reporting relief) were seen in cough, dyspnea, headache, joint pain, pain interference/intensity, pins/needles, subjective relief.
Conclusion
Stellate ganglion block is a promising treatment that appears to generate substantive benefit for many of the symptoms seen in long COVID. However, the current literature has small, uncontrolled studies with heterogenous study designs and follow-up periods. Standardized research with larger sample sizes, control groups, and longer-term follow up is necessary to elucidate the degree of benefit. IRB approval and clinical trial registration not required.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Temple University, 3401 N. Broad St, Philadelphia, PA, 19140, USA. Sudeeprpeddireddy@gmail.com.
- Temple University, 3401 N. Broad St, Philadelphia, PA, 19140, USA.
- Premier Orthopedics, 1204 Baltimore Pike , Chadds Ford, PA, 19317, USA.
Zitieren
APA
Peddireddy, S., VanWingerden, N., Patel, P., Howard, G., & Berger, J. (2026). Stellate Ganglion Block in the Treatment of Long COVID: A Systematic Review. Current Pain and Headache Reports, 30(1). https://doi.org/10.1007/s11916-026-01477-5
Vancouver
Peddireddy S, VanWingerden N, Patel P, Howard G, Berger J. Stellate Ganglion Block in the Treatment of Long COVID: A Systematic Review. Current Pain and Headache Reports. 2026;30(1). doi:10.1007/s11916-026-01477-5
BibTeX
@article{Peddireddy2026,
author = {Peddireddy, Sudeep and VanWingerden, Noah and Patel, Priya and Howard, Gabriel and Berger, Jeffrey},
title = {Stellate Ganglion Block in the Treatment of Long COVID: A Systematic Review},
journal = {Current Pain and Headache Reports},
year = {2026},
volume = {30},
number = {1},
doi = {10.1007/s11916-026-01477-5}
}
EUVIMED